|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 276,500.00 KRW | -4.16% |
|
-14.66% | -38.49% |
| 06-10 | Alteogen Inc Showcases Preclinical Data On ALT-B4-Enabled Subcutaneous ADC Formulation At World ADC Summit | CI |
| 05-08 | Alteogen's Net Income Declines 14% in Q1 | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 324,000 | 375,000 | 369,000 |
| Spread/Res. | -14.66% | -26.27% | -25.07% |
| Spread/Supp. | +5.74% | +25.97% | +1.84% |
| Support | 261,500 | 219,500 | 271,500 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A196170 Stock
- Charts ALTEOGEN Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
